Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Raphael Pharmaceutical Inc. (RAPH) had Weighted-Average Shares Outstanding (Diluted) of 19.63M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-0.32M |
|
-- |
|
-- |
|
$0.32M |
|
$-0.32M |
|
$0.01M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.31M |
|
$-0.32M |
|
$-0.32M |
|
19.63M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
19.63M |
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$0.03M |
|
$0.00M |
|
$0.00M |
|
$0.03M |
|
$1.08M |
|
-- |
|
-- |
|
$1.08M |
|
$-1.05M |
|
$-1.05M |
|
$-1.05M |
|
19.63M |
|
| Cash Flow Statement Financials | |
$-0.24M |
|
-- |
|
$0.24M |
|
$0.02M |
|
$0.02M |
|
$0.00M |
|
$0.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.03 |
|
-- |
|
-- |
|
-- |
|
-0.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.24M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
29.39% |
|
29.39% |
|
-1026.67% |
|
29.39% |
|
$-0.05 |
|
$-0.01 |
|
$-0.01 |
|